Platelet-activating factor enhanced the pressor response of endothelin-1

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 4, 2002, Pages 528-532

  Leung, Susan W S ^a   Man, Godfrey S K ^a   Man, Ricky Y K ^a  

^a Department of Pharmacology ^*  (Hong Kong)

Author keywords

Blood pressure; Endothelin 1; ETA receptors; Platelet activating factor; Rats

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; APAFANT; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; GINKGOLIDE B; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BOLUS INJECTION; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BLOOD PRESSURE; DRUG SYNERGISM; ENDOTHELIN-1; MALE; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0036784874     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200210000-00005     Document Type: Article

References (16)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Yanagisawa M, Inoue A, Ishikawa T, et al. Primary structure, synthesis, and biologic activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 1988;85:6964-7.
3. DeNucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal from the pulmonary circulatation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
4. Lerman A, Sandok EK, Hildebrand FL Jr, et al. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992;85:1894-8.
5. Yang BC, Nichols WW, Lawson DL, et al. 5-hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1. Am J Physiol 1992;262:H931-6.
6. Saijonmaa O, Ristimäki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Comm 1990;173:514-20.
7. Nakayama K, Ishigai Y, Uchida H, et al. Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Br J Pharmacol 1991;104:978-86.
8. Henrion D, Laher I. Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension 1993;22:78-83.
9. Man RYK, Hu W, Kinnaird AAA. Coronary vascular response to platelet-activating factor in the perfused rat heart. J Lipid Mediat 1990;2:75-83.
10. Moritoki H, Hisayama T, Takeuchi S, et al. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol 1992;107:196-201.
11. Kamata K, Numazawa T, Kasuya Y. Characteristics of vasodilatation induced by acetylcholine and platelet-activating factor in the rat mesenteric arterial bed. Eur J Pharmacol 1996;298:129-36.
12. Lagente V, Chabrier PE, Mencia-Huerta JM, et al. Pharmacological modulation of the bronchopulmonary action of the vasoactive peptie, endothelin, administered by aerosol in the guinea-pig. Biochem Biophys Res Commun 1989;158:625-32.
13. Filep JG, Sirois MG, Rouseau A, et al. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol 1991;104:797-804.
14. Montero A, Rodriguez-Barbero A, López-Novoa JM. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. Eur J Pharmacol 1993;43:235-40.
15. Takayasu M, Kondo K, Terao S. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2. Biochem Biophys Res Commun 1989;160:751-7.
16. Yasuda M, Kohno M, Tahara A, et al. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990;119:801-6.